Retention and Duration of Activity of SPL7013 (VivaGel®) After Vaginal Dosing.

Clinical trial NCT00740584 · COMPLETED

Trial details

NCT number: NCT00740584
Sponsor: Starpharma Pty Ltd
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

HIV Infections HSV-2 Genital Herpes

Start date: 2008-08-01
Primary completion: 2009-03-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.